Your Complete News View.
Published loading...Updated

Motley Fool: Risks and potential

Summary by The Spokesman-Review
Shares of pharmaceutical company Merck (NYSE: MRK) were recently down about 40% over the past year, partly due to concerns about global tariff risks.

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The spokesman-Review broke the news in Spokane, United States on Sunday, June 15, 2025.
Sources are mostly out of (0)